Organogenesis Holdings Inc (NASDAQ:ORGO) price on Thursday, July 03, rose 4.94% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.25.
A look at the stock’s price movement, the close in the last trading session was $4.05, moving within a range at $4.01 and $4.25. The beta value (5-Year monthly) was 1.635. Turning to its 52-week performance, $6.71 and $2.28 were the 52-week high and 52-week low respectively. Overall, ORGO moved 51.25% over the past month.
Organogenesis Holdings Inc’s market cap currently stands at around $539.13 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ORGO is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend ORGO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ORGO’s current price about 24.02% and 17.23% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 71.67, while 7-day volatility ratio is 6.44% and 6.58% in the 30-day chart. Further, Organogenesis Holdings Inc (ORGO) has a beta value of 1.75. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -41.18% off current price level while to achieve the yearly target high, price needs to move -41.18%. Nonetheless, investors will most likely welcome a -41.18% jump to $6 which is the analysts’ median price.
If we refocus on Organogenesis Holdings Inc (NASDAQ:ORGO), historical trading data shows that trading volumes averaged 1.08 over the past 10 days and 1.43 million over the past 3 months. The company’s latest data on shares outstanding shows there are 126.85 million shares.
The 49.43% of Organogenesis Holdings Inc’s shares are in the hands of company insiders while institutional holders own 51.46% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 10.81 million on 2025-06-13, giving us a short ratio of 10.89. The data shows that as of 2025-06-13 short interest in Organogenesis Holdings Inc (ORGO) stood at 2478.0000999999997 of shares outstanding, with shares short falling to 12.1 million registered in 2025-05-15. Current price change has pushed the stock 57.41% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ORGO stock continues to rise going into the next quarter.
